Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triapine and Cisplatin in Recurrent or Metastatic Esophageal Adenocarcinoma
NCT00077545Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2004
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triapine in esophageal adenocarcinoma (EAC), adenocarcinoma of the gastroesophageal junction, sponsored by National Cancer Institute. Started Jan 2004; status: completed.
02
Drugs
triapine
03
Conditions
esophageal adenocarcinoma (EAC)adenocarcinoma of the gastroesophageal junction
Beyond the preview
Go deeper on NCT00077545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077545.